Related Experiment Video
Updated: Jun 28, 2026

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
Published on: October 28, 2014
Autologous blood programs: what is happening?
1Department of Pathology, The University of Ottawa, Canadian Apheresis Group, Suite 199, 435 St. Laurent Boulevard, Ottawa, Ontario, Canada K1K 2Z8. cag@ca.inter.net
Autologous blood programs in Ontario show significant variability in service provision and integration with Canadian Blood Services (CBS). This contrasts with standardized whole blood and apheresis collections, highlighting a need for greater consistency in autologous blood services.
Area of Science:
- Transfusion Medicine
- Healthcare Management
Background:
- Preoperative autologous blood collection has gained prominence, particularly post-AIDS epidemic.
- Despite increased application, autologous blood programs face both praise and criticism, with limited data on their actual implementation.
Purpose of the Study:
- To assess the demographics, logistics, and funding of autologous blood programs in Ontario's largest hospitals.
- To identify variations in autologous blood service availability and operation across the province.
Main Methods:
- A survey was distributed to 155 large hospitals in Ontario.
- 78 hospitals responded, providing data on their autologous blood program access, structure, and funding.
Main Results:
- 77 of 78 responding hospitals had access to an autologous program.
- 26 hospitals had in-house programs, while 62 utilized Canadian Blood Services (CBS).
- 15 hospitals lacked any autologous program access; some programs were funded by patient fees.
Conclusions:
- Autologous blood programs in Ontario exhibit considerable variability, with some regions lacking services while others have active programs.
- This variability contrasts sharply with the standardized approach to whole blood and apheresis collections managed by CBS.
- There is a notable lack of standardization in autologous blood collection services across Canadian provinces.
Related Concept Videos
iPS Cell Differentiation
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
EPS and iPS Cells in Disease Research
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
